Axsome Therapeutics (AXSM) Leases: 2022-2025
Historic Leases for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to $21.7 million.
- Axsome Therapeutics' Leases rose 277.91% to $21.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.7 million, marking a year-over-year increase of 277.91%. This contributed to the annual value of $5.4 million for FY2024, which is 20.51% down from last year.
- As of Q3 2025, Axsome Therapeutics' Leases stood at $21.7 million, which was down 3.64% from $22.5 million recorded in Q2 2025.
- Axsome Therapeutics' Leases' 5-year high stood at $23.3 million during Q1 2025, with a 5-year trough of $106,000 in Q1 2023.
- Over the past 3 years, Axsome Therapeutics' median Leases value was $6.8 million (recorded in 2023), while the average stood at $10.2 million.
- In the last 5 years, Axsome Therapeutics' Leases tumbled by 88.80% in 2023 and then spiked by 5,948.11% in 2024.
- Quarterly analysis of 4 years shows Axsome Therapeutics' Leases stood at $420,000 in 2022, then spiked by 1,512.38% to $6.8 million in 2023, then dropped by 20.51% to $5.4 million in 2024, then soared by 277.91% to $21.7 million in 2025.
- Its last three reported values are $21.7 million in Q3 2025, $22.5 million for Q2 2025, and $23.3 million during Q1 2025.